SEC Form 4 · accession 0001209191-19-007127
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven W Spector
Officer — EVP, General Counsel & Sec
Period of report
Feb 1, 2019
Accepted (ET)
Feb 4, 2019 · 7:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 1, 2019 | M | 1,500 | $40.10 | A | 21,190 | D | |
| Common Stock | Feb 1, 2019 | S | 1,500 | $46.10 | D | 19,690 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $40.10 | Feb 1, 2019 | M | 1,500 | D | — | Mar 17, 2019 | Common Stock | 1,500 | 0 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person.
- F2The options vested in four equal annual installments beginning on March 17, 2010, and were immediately exercisable once vested.